<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05117411</url>
  </required_header>
  <id_info>
    <org_study_id>09/21</org_study_id>
    <nct_id>NCT05117411</nct_id>
  </id_info>
  <brief_title>Optical Coherence Tomography Angiography and Pseudophakic Cystoid Edema</brief_title>
  <official_title>Peripapillary Vascular Density in the Pathogenesis of Pseudophakic Cystoid Edema</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Federico II University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Federico II University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study evaluates the retinal vascular features in macula and papillary regions in&#xD;
      patients affected by pseudophakic cystoid edema using optical coherence tomography&#xD;
      angiography&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Pseudophakic cystoid edema represents one of the most common causes of poor visual outcome&#xD;
      following cataratta surgery.&#xD;
&#xD;
      It is still source of debate the pathogenesis of Pseudophakic cystoid edema. Optical&#xD;
      coherence tomography angiography represents a novel and non-invasive diagnostic technique&#xD;
      that allows a detailed analysis of retinal vascular features. The study evaluates&#xD;
      retrospectively the changes in optical coherence tomography angiography parameters at&#xD;
      baseline and after three monthly after surgery.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Actual">December 30, 2020</completion_date>
  <primary_completion_date type="Actual">December 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>OCTA and pseudophakic cystoid macular oedema</measure>
    <time_frame>3 months</time_frame>
    <description>The parameters analyzed by OCTA three months after surgery are:&#xD;
Vessel density (%) of superficial capillary plexus, deep capillary plexus, coriocapillary plexus in macular region Vessel density (%) of radial peripapillary capillary plexus in papilllary region</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">25</enrollment>
  <condition>Pseudophakic Cystoid Macular Edema</condition>
  <arm_group>
    <arm_group_label>Patients group</arm_group_label>
    <description>Subjects over 18 years that after cataract surgery, showed pseudophakic cystoid macula edema.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <description>Normal subjects over 18 years that did not show pseudophakic cystoid macula edema.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>OCTA and pseudophakin cystoid edema</intervention_name>
    <description>Patients underwent OCT angiografia after cataract surgery</description>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_label>Patients group</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        The participans were older than 18 years with diagnosis of pseudophakic cystoid macular&#xD;
        oedema. The participans did not present other ophthalmological diseases.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  age older than 60 years&#xD;
&#xD;
          -  diagnosis of pseudophakic cystoid macular oedema&#xD;
&#xD;
          -  treatment-naïve for pseudophakic cystoid macular oedema&#xD;
&#xD;
          -  absence of other ocular diseases, responsible for macular edema (retinal vein&#xD;
             occlusion, diabetic retinopathy, age-related macular degeneration)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  age younger than 60 years&#xD;
&#xD;
          -  No diagnosis of pseudophakic cystoid macular oedema&#xD;
&#xD;
          -  previous treatment for pseudophakic cystoid macular oedema&#xD;
&#xD;
          -  presence of other ocular diseases, responsible for macular edema (retinal vein&#xD;
             occlusion, diabetic retinopathy, age-related macular degeneration)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>60 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gilda Cennamo</last_name>
    <role>Principal Investigator</role>
    <affiliation>Università Federico II</affiliation>
  </overall_official>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>September 27, 2021</study_first_submitted>
  <study_first_submitted_qc>November 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 11, 2021</study_first_posted>
  <last_update_submitted>November 2, 2021</last_update_submitted>
  <last_update_submitted_qc>November 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Federico II University</investigator_affiliation>
    <investigator_full_name>Gilda Cennamo</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Macular Edema</mesh_term>
    <mesh_term>Edema</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

